DSS INC. overview

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, today announced financial results for the first quarter of 2025, highlighting meaningful progress in its financial repositioning and a strong foundation for corporate execution in the coming quarters. In a quarter focused on streamlining operations and financial discipline, DSS delivered significant...

Elavon and Jscrambler Partner to Strengthen PCI DSS Compliance for Merchants PR Newswire MINNEAPOLIS and PORTO, Portugal, May 7, 2025 More Than 400 Merchants Within the Network Gain Access to Jscrambler's Leading Client-Side Protection for Skimming Prevention and Compliance MINNEAPOLIS and PORTO, Portugal , May 7, 2025 /PRNewswire/ -- Elavon , a global leader in payment processing, and Jscrambler , a pioneer in client-side protection and compliance, today announced a partnership to help...

Elavon and Jscrambler Partner to Strengthen PCI DSS Compliance for Merchants PR Newswire MINNEAPOLIS and PORTO, Portugal, May 7, 2025 More Than 400 Merchants Within the Network Gain Access to Jscrambler's Leading Client-Side Protection for Skimming Prevention and Compliance MINNEAPOLIS and PORTO, Portugal , May 7, 2025 /PRNewswire/ -- Elavon , a global leader in payment processing, and Jscrambler , a pioneer in client-side protection and compliance, today announced a partnership to help...

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sentinel Brokers Company, Inc. (“Sentinel”), a FINRA-registered broker-dealer and a subsidiary of DSS, Inc. (NYSE American: DSS), is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to act as an underwriter and selling group member for corporate securities offerings. This regulatory milestone significantly enhances Sentinel’s capabilities in the capital markets, enabling the firm to...

ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air purification asset to Impact BioMedical Inc. (NYSE American: IBO) in a strategic, all-equity transaction valued at approximately $1.15 million. This divestiture aligns with DSS’ ongoing strategy to optimize its portfolio and concentrate on core growth areas. Celios® is a cutting-edge air...

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops assets to increase shareholder value, today issued the following letter to shareholders: Dear Esteemed Shareholders, I am pleased to provide you with significant updates regarding the leadership of DSS, Inc. and to outline the strategic direction we are pursuing as a Company. It is with great honor that...

dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region PR Newswire SINGAPORE, Jan. 21, 2025 SINGAPORE , Jan. 21, 2025 /PRNewswire/ -- dss⁺ announced today strategic leadership changes to its Executive Leadership Team (ELT) in Asia Pacific . These changes support the company's goals to accelerate impact on clients, develop internal talent, and deliver on its purpose of saving lives and creating a...

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of Impact BioMedical's initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness solutions, has set its IPO price at $3.00 per share, with an initial offering of 1,500,000 shares. Trading under the ticker symbol “IBO,” these shares will...